Objective To evaluate the clinical efficacy and safety of Zhenzhu Qingyuan Granules through a clinical randomized controlled trial and to analyze the potential action targets and pathways of this formula using network...Objective To evaluate the clinical efficacy and safety of Zhenzhu Qingyuan Granules through a clinical randomized controlled trial and to analyze the potential action targets and pathways of this formula using network pharmacology.Methods Patients with gastroesophageal reflux disease(GERD)of liver–stomach stagnant heat pattern who met the inclusion and exclusion criteria were randomly divided into the control group and the observation group.The control group received oral rabeprazole,whereas the observation group were given Zhenzhu Qingyuan Granules in addition to the rabeprazole.The treatment duration was 8 weeks.Clinical efficacy was observed in both groups after 8 weeks.Network pharmacology was used to analyze the action targets of ZhenzhuQingyuanGranules and the genes related to GERD,and core targets were inferred.Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were conducted to explore the potential mechanisms of this formula.Results The clinical research results showed that the total effective rate in the treatment group was 92.68%,compared with 70.00%in the control group,with a statistically significant difference(p<0.05).After treatment,both Chinese medicine syndrome score and endoscopic score improved in both groups compared with before treatment(p<0.05),and the treatment group showed greater improvement than the control group(p<0.05).Network pharmacology identified effective components of Zhenzhu Qingyuan Granules for treating GERD,including quercetin,luteolin,andβ-sitosterol,with potential action targets such as tumor protein 53(TP53),protein kinase B(AKT1),and tumor necrosis factor.Conclusion Zhenzhu Qingyuan Granules can significantly improve clinical symptoms in patients with GERD of liver–stomach stagnated heat pattern,enhance clinical efficacy,and have high safety.This formula may exert therapeutic effects through multiple targets and pathways.展开更多
反流性食管炎(RE)是指由于胃和(或)十二指肠内容物反流入食管,引起食管粘膜损害,即患者不仅有胃食管反流(GER),食管还存在炎性损害.原发性食管胃肠运动功能障碍是引起胃食管反流病(GERD)的主要原因.食管运动功能与GERP 密切相关,其中 L...反流性食管炎(RE)是指由于胃和(或)十二指肠内容物反流入食管,引起食管粘膜损害,即患者不仅有胃食管反流(GER),食管还存在炎性损害.原发性食管胃肠运动功能障碍是引起胃食管反流病(GERD)的主要原因.食管运动功能与GERP 密切相关,其中 LES 和食管的清除功能最为重要,其他如 His 角,胃斜行肌、隔肌食管韧带等也具有防反流的作用.LES 静止压,低于10mmmHg 时,出现 GER 的可能性大,胃伸展扩张的刺激和胃排空延迟均可引起一过性 LES 弛缓,使食管酸暴露时间延长,一过性 LES 弛缓是发生 GER 的主要机制,RE患者中2/3是因 LES 一过性弛缓所致,一过性弛缓时间可达10S以上或持续超过30s.展开更多
基金National Administration of Traditional Chinese Medicine Evidence-Based Capacity Building Project(2019XZZXXH005)Special Project on Traditional Chinese Medicine Scientific Research of Health Commission of Henan Province(2022ZY2022)+1 种基金Henan Provincial Top Talents Cultivation Project in Traditional Chinese Medicine Discipline of Henan Provincial Traditional Chinese Medicine Inheritance and Innovation Talents Project(Zhongjing Project)(Henan Health TraditionalMedicine Letter[2021]No.15)Special Project on Traditional Chinese Medicine Scientific Research of Health Commission of Henan Province(2023ZY2062).
文摘Objective To evaluate the clinical efficacy and safety of Zhenzhu Qingyuan Granules through a clinical randomized controlled trial and to analyze the potential action targets and pathways of this formula using network pharmacology.Methods Patients with gastroesophageal reflux disease(GERD)of liver–stomach stagnant heat pattern who met the inclusion and exclusion criteria were randomly divided into the control group and the observation group.The control group received oral rabeprazole,whereas the observation group were given Zhenzhu Qingyuan Granules in addition to the rabeprazole.The treatment duration was 8 weeks.Clinical efficacy was observed in both groups after 8 weeks.Network pharmacology was used to analyze the action targets of ZhenzhuQingyuanGranules and the genes related to GERD,and core targets were inferred.Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were conducted to explore the potential mechanisms of this formula.Results The clinical research results showed that the total effective rate in the treatment group was 92.68%,compared with 70.00%in the control group,with a statistically significant difference(p<0.05).After treatment,both Chinese medicine syndrome score and endoscopic score improved in both groups compared with before treatment(p<0.05),and the treatment group showed greater improvement than the control group(p<0.05).Network pharmacology identified effective components of Zhenzhu Qingyuan Granules for treating GERD,including quercetin,luteolin,andβ-sitosterol,with potential action targets such as tumor protein 53(TP53),protein kinase B(AKT1),and tumor necrosis factor.Conclusion Zhenzhu Qingyuan Granules can significantly improve clinical symptoms in patients with GERD of liver–stomach stagnated heat pattern,enhance clinical efficacy,and have high safety.This formula may exert therapeutic effects through multiple targets and pathways.
文摘反流性食管炎(RE)是指由于胃和(或)十二指肠内容物反流入食管,引起食管粘膜损害,即患者不仅有胃食管反流(GER),食管还存在炎性损害.原发性食管胃肠运动功能障碍是引起胃食管反流病(GERD)的主要原因.食管运动功能与GERP 密切相关,其中 LES 和食管的清除功能最为重要,其他如 His 角,胃斜行肌、隔肌食管韧带等也具有防反流的作用.LES 静止压,低于10mmmHg 时,出现 GER 的可能性大,胃伸展扩张的刺激和胃排空延迟均可引起一过性 LES 弛缓,使食管酸暴露时间延长,一过性 LES 弛缓是发生 GER 的主要机制,RE患者中2/3是因 LES 一过性弛缓所致,一过性弛缓时间可达10S以上或持续超过30s.
